Our results are supported by previous studies which show that palmostatin B mediated inhibition of APT-1 and -2 affects HRASG12 transformed fibroblasts, NRASG12 transformed fetal liver cells and NRAS mutant leukemia cells [26,42]. The gene discussed is LYPLA1; the disease is leukemia.